IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q4 2022 Holdings

Filed 2023-02-14 | 17 holdings | $39.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Savara Inc(SVRA)COM805111101$10.7M6,896,55127.3%
Xeris Biopharma Holdings Inc(XERS)COM98422E103$8.0M6,039,02820.5%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$6.1M15,94715.6%
Rezolute Inc(RZLT)COM NEW76200L309$2.9M1,403,1577.4%
Scynexis Inc(SCYX)COM NEW811292200$2.7M1,723,9476.9%
Spdr SER TR(XOP)S&P OILGAS EXP78468R556$2.4M17,5006.1%
Vectivbio Hldg AGORD SHSH9060V101$1.3M156,2223.4%
Arcellx Inc(ACLX)COMMON STOCK03940C100$1.1M36,3022.9%
Alps ETF TR(AMLP)ALERIAN MLP00162Q452$1.1M29,5002.9%
Compass Therapeutics Inc(CMPX)COM20454B104$1.1M211,1592.7%
Cabaletta BIO Inc(CABA)COM12674W109$783.7K84,7282.0%
Molecular Templates IncCOM608550109$673.4K2,052,9911.7%
Allakos Inc(ALLKGUSD)COM01671P100$153.8K18,2710.4%
Elevation Oncology IncCOM28623U101$64.8K68,3240.2%
Newamsterdam Pharma Company*W EXP 11/22/202N62509117$17.8K21,3330.0%
Bridgetown Holdings LTD*W EXP 09/30/202G1355U121$4.7K39,7730.0%
Lanvin Group Holdings Limite*W EXP 99/99/999G5380J118$3.8K12,0000.0%